Most Recent Annual Report
2019 Annual Report
Oxford Biomedica does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.
Oxford Biomedica
About Oxford Biomedica
201-500 Employees
Based in Oxford, England
Oxford BioMedica (LSE:OXB) is a leading gene and cell therapy company focused on developing life-changing treatments for serious diseases. Oxford BioMedica and its subsidiaries (the “Group”) have built a sector leading lentiviral vector delivery platform (LentiVector®) through which the Group develops in vivo and ex-vivo products both in-house and with partners. The Group has created a valuable proprietary portfolio of gene and cell therapy product candidates in the areas of oncology, ophthalmology and CNS disorders.
- Ticker:
- OXB
- Exchange:
- LSE (See More LSE Companies)
- Industry:
- Biotechnology (See More Biotechnology Companies)
- Sector:
- Healthcare (See More Healthcare Companies)